Michael Chen to Phenylcarbamates
This is a "connection" page, showing publications Michael Chen has written about Phenylcarbamates.
Connection Strength
0.127
-
Cummings JL, Koumaras B, Chen M, Mirski D. Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: a 26-week, multicenter, open-label study. Am J Geriatr Pharmacother. 2005 Sep; 3(3):137-48.
Score: 0.066
-
Aupperle PM, Koumaras B, Chen M, Rabinowicz A, Mirski D. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study. Curr Med Res Opin. 2004 Oct; 20(10):1605-12.
Score: 0.062